This invention describes a way to boost the amount of usable cysteine in an animal's body. It uses a special cycling molecule that can move in and out of cells, converting a less usable form of cysteine (cystine) found outside cells into the more beneficial cysteine. The patent specifically claims this method for treating conditions linked to cysteine depletion, such as hyperpigmentation from arsenic poisoning, high glycated hemoglobin in diabetes, and glycated LDL in heart disease.
Why it matters: Advances in computational chemistry and drug screening since 2007 could accelerate identifying suitable membrane-permeable thiol molecules. However, the significant hurdle of clinical validation for these specific conditions persists.
AI gives you a few directions you could take this. Pick one, and we check whether your version is different enough to patent, then write the filing.
Reinvent this with AI